Bioelectric Medicine Ready for Prime Time as Companies Advance Therapies
Bioelectric medicine is coming into its own as a combination or stand-alone therapy for a growing cohort of conditions. Big pharma has funded programs, international coalitions have formed and the National Institutes of Health (NIH) and the Defense Acquisition Research Agency (DARPA) each are making sizeable research investments. The field, panelists at a recent Demy-Colton Virtual Salon agreed, holds huge promise.
Targeted delivery of energy – biomedicine – can be used to treat chronic diseases of the nervous system, inflammatory conditions, autonomic disorders and metabolic diseases. It may even be possible to treat heart conditions, oncology, pain, and gastric, urologic, and ophthalmic conditions such as chronic dry eye.